|
[1]
|
Reske-Nielsen E,Lundbæk K,Rafaelsen O J. Pathological changes in the central and peripheral nervous system of young long-term diabetics:I. Diabetic encephalopathy[J]. Diabetologia,1966,1(3-4):233-241. doi: 10.1007/BF01257917
|
|
[2]
|
Mijnhout G S,Scheltens P,Diamant M,et al. Diabetic encephalopathy:A concept in need of a definition[J]. Diabetologia,2006,49(6):1447-1448. doi: 10.1007/s00125-006-0221-8
|
|
[3]
|
Gudala K,Bansal D,Schifano F,et al. Diabetes mellitus and risk of dementia:A meta-analysis of prospective observational studies[J]. J Diabetes Investig,2013,4(6):640-650.
|
|
[4]
|
Leszek J,Trypka E,Tarasov V V,et al. Type 3 diabetes mellitus:A novel implication of alzheimers disease[J]. Curr Top Med Chem,2017,17(12):1331-1335. doi: 10.2174/1568026617666170103163403
|
|
[5]
|
International Diabetes Federation. IDF diabetes atlas[M]. 10th ed. Brussels, Belgium: International Diabetes Federation, 2021: 1-141.
|
|
[6]
|
Brownlee M. Biochemistry and molecular cell biology of diabetic complications[J]. Nature,2001,414(6865):813-820. doi: 10.1038/414813a
|
|
[7]
|
Cardoso S,Correia S C,Santos R X,et al. Hyperglycemia,hypoglycemia and dementia:roleof mitochondria and uncoupling proteins[J]. Curr Mol Med,2013,13(4):586-601.
|
|
[8]
|
Launer L J,Miller M E,Williamson J D,et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND):A randomised open-label substudy[J]. Lancet Neurol,2011,10(11):969-977. doi: 10.1016/S1474-4422(11)70188-0
|
|
[9]
|
Hwang J J,Parikh L,Lacadie C,et al. Hypoglycemia unawareness in type 1 diabetes suppresses brain responses to hypoglycemia[J]. J Clin Invest,2018,128(4):1485-1495. doi: 10.1172/JCI97696
|
|
[10]
|
Geijselaers S L,Sep S J,Stehouwer C D,et al. Glucose regulation,cognition,and brain MRI in type 2 diabetes:A systematic review[J]. Lancet Diabetes Endocrinol,2015,3(1):75-89. doi: 10.1016/S2213-8587(14)70148-2
|
|
[11]
|
Walker K A,Power M C,Gottesman R F. Defining the relationship between hypertension,cognitive decline,and dementia:A review[J]. Curr Hypertens Rep,2017,19(3):24. doi: 10.1007/s11906-017-0724-3
|
|
[12]
|
Ma C,Yin Z,Zhu P,et al. Blood cholesterol in late-life and cognitive decline:a longitudinal study of the Chinese elderly[J]. Mol Neurodegener,2017,12(1):24. doi: 10.1186/s13024-017-0167-y
|
|
[13]
|
李睿,刘扬,陈伟红,等. 血脂异常和他汀类药物对认知功能的影响[J]. 国际神经病学神经外科学杂志,2018,45(5):528-532.
|
|
[14]
|
Dye L,Boyle N B,Champ C,et al. The relationnship between obesity and cognitive health and decline[J]. Proceedings of the Nutrition Society,2017,76(4):443-454. doi: 10.1017/S0029665117002014
|
|
[15]
|
Rebelos E,Rinne J O,Nuutila P,et al. Brain glucose metabolism in health,obesity,and cognitive decline-does insulin have anything to do with it? A narrative review[J]. J Clin Med,2021,10(7):1532. doi: 10.3390/jcm10071532
|
|
[16]
|
孙芩玲,雷曦,曹英,等. 吸烟对中老年人轻度认知功能障碍的影响[J]. 湖北医药学院学报,2017,36(4):330-333,337.
|
|
[17]
|
Swan G E,Lessov-Schlaggar C N. The effects of tobacco smoke and nicotine on cognition and the brain[J]. Neuropsychol Rev,2007,17(3):259-273. doi: 10.1007/s11065-007-9035-9
|
|
[18]
|
刘申贝,古小云,钟志江,等. KKAy糖尿病脑病模型的探索及相关机制研究[J]. 中药药理与临床,2020,36(1):210-218.
|
|
[19]
|
den Heijer T,Vermeer S E,van Dijk E J,et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI[J]. Diabetologia,2003,46(12):1604-1610. doi: 10.1007/s00125-003-1235-0
|
|
[20]
|
刘雪梅,谢明国. 3.0T MRI弥散张量成像(DTI)在诊断早期糖尿病脑病中的应用[J]. 糖尿病新世界,2020,23(13):18-19.
|
|
[21]
|
尹华静,王伟平,王晓良. 糖尿病脑病突触可塑性损伤的研究进展[J]. 中国药学杂志,2018,53(21):1805-1809.
|
|
[22]
|
Liu Y,Li M,Zhang Z,et al. Role of microglia-neuron interactions in diabetic encephalopathy[J]. Ageing Res Rev,2018,42:28-39.
|
|
[23]
|
Lampron A,Elali A,Rivest S. Innate immunity in the CNS:redefining the relationship between the CNS and Its environment[J]. Neuron,2013,78(2):214-232. doi: 10.1016/j.neuron.2013.04.005
|
|
[24]
|
Abdelwahed O M,Tork O M,Gamal El Din M M,et al. Effect of glucagon-like peptide-1 analogue; Exendin-4,on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin[J]. Brain Res Bull,2018,139:67-80.
|
|
[25]
|
刘慧,王小军,胡蓉,等. 星形胶质细胞[J]. 生命科学进展,2004,35(1):86-91.
|
|
[26]
|
师思,王晓良. 星形胶质细胞在糖尿病脑病中的变化及作用[J]. 国际药学研究杂志,2016,43(1):56-61.
|
|
[27]
|
Shimizu F,Sano Y,Tominaga O,et al. Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-β by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro[J]. Neurobiol Aging,2013,34(7):1902-1912. doi: 10.1016/j.neurobiolaging.2013.01.012
|
|
[28]
|
van Sloten T T,Sedaghat S,Carnethon M R,et al. Cerebral microvascular complications of type 2 diabetes:stroke,cognitive dysfunction,and depression[J]. Lancet Diabetes Endocrinol,2020,8(4):325-336. doi: 10.1016/S2213-8587(19)30405-X
|
|
[29]
|
Emerging Risk Factors Collaboration,Sarwar N,Gao P,et al. Diabetes mellitus,fasting blood glucose concentration,and risk of vascular disease:a collaborative meta-analysis of 102 prospective studies[J]. Lancet,2010,375(9733):2215-2222. doi: 10.1016/S0140-6736(10)60484-9
|
|
[30]
|
Cheng G,Huang C,Deng H,et al. Diabetes as a risk factor for dementia and mild cognitive impairment:a meta-analysis of longitudinal studies[J]. Intern Med J,2012,42(5):484-491. doi: 10.1111/j.1445-5994.2012.02758.x
|
|
[31]
|
Ly H,Despa F. Diabetes-related amylin dyshomeostasis:A contributing factor to cerebrovascular pathology and dementia[J]. J Lipid Atheroscler,2019,8(2):144-151. doi: 10.12997/jla.2019.8.2.144
|
|
[32]
|
Verma N,Despa F. Contributing factors to diabetic brain injury and cognitive decline[J]. Diabetes Metab J,2019,43(5):560-567.
|
|
[33]
|
Grieco G E,Brusco N,Licata G,et al. Targeting microRNAs as a therapeutic strategy to reduce oxidative stress in diabetes[J]. Int J Mol Sci,2019,20(24):6358. doi: 10.3390/ijms20246358
|
|
[34]
|
Wang B,Huang J,Li J,et al. Control of macrophage autophagy by miR-384-5p in the development of diabetic encephalopathy[J]. Am J Transl Res,2018,10(2):511-518.
|
|
[35]
|
Shi L,Zhang R,Li T,et al. Decreased miR-132 plays a crucial role in diabetic encephalopathy by regulating the GSK-3β/Tau pathway[J]. Aging (Albany NY),2020,13(3):4590-4604.
|
|
[36]
|
Lei Y,Yang M,Li H,et al. miR-130b regulates PTEN to activate the PI3K/Akt signaling pathway and attenuate oxidative stress-induced injury in diabetic encephalopathy[J]. Int J Mol Med,2021,48(1):141. doi: 10.3892/ijmm.2021.4974
|
|
[37]
|
Mizushima N,Komatsu M. Autophagy:renovation of cells and tissues[J]. Cell,2011,147(4):728-741. doi: 10.1016/j.cell.2011.10.026
|
|
[38]
|
Shao B Z,Han B Z,Zeng Y X,et al. The roles of macrophage autophagy in atherosclerosis[J]. Acta Pharmacol Sin,2016,37(2):150-156. doi: 10.1038/aps.2015.87
|
|
[39]
|
Wang B,Zhong Y,Li Q,et al. Autophagy of macrophages is regulated byPI3k/Akt/mTOR signalling in the development of diabeticencephalopathy[J]. Aging (Albany NY),2018,10(10):2772-2782. doi: 10.18632/aging.101586
|
|
[40]
|
Xie M,Wang M,Liu W,et al. Lipin1 is involved in the pathogenesis of diabetic encephalopathy through the PKD/limk/cofilin signaling pathway[J]. Oxid Med Cell Longev,2020,2020:1723423.
|
|
[41]
|
Chen R,Shi J,Yin Q,et al. Morphological and pathological characteristics of brain in diabetic encephalopathy[J]. JAlzheimers Dis,2018,65(1):15-28. doi: 10.3233/JAD-180314
|
|
[42]
|
景光婵,张梦仁. 糖尿病脑病的氧化应激损伤及治疗[J]. 中国糖尿病杂志,2011,19(1):68-70. doi: 10.3969/j.issn.1006-6187.2011.01.018
|
|
[43]
|
Luc K,Schramm-Luc A,Guzik T J,et al. Oxidative stress and inflam-matory markers in prediabetes and diabetes[J]. J PhysiolPharmacol,2019,70(6):809-824.
|
|
[44]
|
Wang Z,Huang Y,Cheng Y,et al. Endoplasmic reticulum stress-induced neuronal inflammatory response and apoptosis likely plays a key role in the development of diabetic encephalopathy[J]. Oncotarget,2016,7(48):78455-78472. doi: 10.18632/oncotarget.12925
|
|
[45]
|
Fernandes V,Choudhary M,Kumar A,et al. Proteotoxicity and mitochondrial dynamics in aging diabetic brain[J]. Pharmacol Res,2020,159:104948.
|
|
[46]
|
Powers E T,Morimoto R I,Dillin A,et al. Biological and chemical approaches to diseases of proteostasis deficiency[J]. Annu Rev Biochem,2009,78(2009):959-991.
|
|
[47]
|
赵子艾. A2AR活化在脑创伤后tau蛋白过度磷酸化及认知障碍中的作用与机制[D]. 重庆: 第三军医大学, 2014.
|
|
[48]
|
Singhal K,Sandhir R. L-type calcium channel blocker ameliorates diabetic encephalopathy by modulating dysregulated calcium homeostasis[J]. J Neurosci Res,2015,93(2):296-308. doi: 10.1002/jnr.23478
|
|
[49]
|
Huo M,Wang Z,Fu W,et al. Spatially resolved metabolomics based on air-flow-assisted desorption electrospray ionization-mass spectrometry imaging reveals region-specific metabolic alterations in diabetic encephalopathy[J]. J Proteome Res,2021,20(7):3567-3579. doi: 10.1021/acs.jproteome.1c00179
|
|
[50]
|
Xu T,Liu J,Li X R,et al. The mTOR/NF-κB pathway mediates neuroinflammation and synaptic plasticity in diabetic encephalopathy[J]. Mol Neurobiol,2021,58(8):3848-3862. doi: 10.1007/s12035-021-02390-1
|